Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension
- 16 June 2006
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 110 (2) , 175-178
- https://doi.org/10.1016/j.ijcard.2005.07.008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Urotensin II: A Vascular Mediator in Health and DiseaseCurrent Vascular Pharmacology, 2005
- Plasma concentration of urotensin II is raised in hypertensionJournal Of Hypertension, 2004
- Urotensin II: the old kid in townTrends in Endocrinology & Metabolism, 2004
- Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: a “vasoconstrictor” with a unique hemodynamic profileAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- From ‘gills to pills’: urotensin-II as a regulator of mammalian cardiorenal functionTrends in Pharmacological Sciences, 2004
- Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic ActionsHypertension, 2003
- Direct Actions of Urotensin II on the HeartCirculation Research, 2003
- Congestive heart failure and expression of myocardial urotensin IIThe Lancet, 2002
- Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkeyBritish Journal of Pharmacology, 2000
- Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertensionEuropean Heart Journal, 1998